Diabetic retinopathy therapeutic pipeline analysis is projected to grow as perceived by the current situation of increasing prevalence of diabetes, globally. Some of the main factors driving the pipeline analysis for diabetic retinopathy include obesity, incidence of diabetes mellitus, stress conditions and increasing prevalence of diabetic retinopathy, low market penetration since a limited number of companies are making an analog and increasing awareness of health issues. According to the data by National Eye Institute, the prevalence of diabetic retinopathy has been increasing mainly in Hispanic and white population. The disease affects equally in both male and female.
Diabetic retinopathy is a type of an eye disease, that affect mostly people with diabetes. The other condition associated with the disease include cataract, diabetic macular edema and glaucoma. All these conditions are have the potential to cause blindness and vision loss. Diabetic retinopathy leads to leakage of blood vessels which distort the vision and sometimes swelling occurs in macula region in case of diabetic macular edema. The major cause of diabetic retinopathy is high blood sugar level which damages the tiny blood vessels in retina, and can also cause haemorrhage. Diabetic retinopathy can occur in four stages namely; mild, moderate, severe and proliferative diabetic retinopathy. In mild conditions swelling of retina blood vessels occur which become distorted in moderate stage due to blockage of blood flow. This leads to the growth of new blood vessels in severe case and in proliferative stage, retinal detachment occurs which can lead to permanent vision loss. Diabetic retinopathy can be diagnosed by visual acuity testing, pupil dilation, tonometry and optical coherence tomography.
Request for Table of Content at: https://www.psmarketresearch.com/market-analysis/diabetic-retinopathy-therapeutics-pipeline-analysis/toc-sample
Some of the companies having a pipeline of diabetic retinopathy therapeutics include Bayer, Novartis, F. Hoffmann-La Roche, Alimera Science, Valeant Pharmaceutical, Inc., Abbott Laboratories, Pfizer, Inc. Regeneron Pharmaceutical, ThromboGenics, Inc., Ampio Pharmaceuticals, Inc.
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY – 10016
Toll-free: +1-888-778-7886 (USA/Canada)